Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis - Wickel, J; Chung, HY; Platzer, S (Trials, 2020)
et al.